Orelox



Indications and Reactions:

Role Indications Reactions
Primary
Bronchitis 21.4%
Ill-defined Disorder 13.3%
Drug Use For Unknown Indication 9.2%
Atrial Fibrillation 8.2%
Hypertension 6.1%
Ovulation Induction 6.1%
Sinusitis 4.1%
Urinary Tract Infection 4.1%
Gastritis 3.1%
Perinephric Abscess 3.1%
Pyrexia 3.1%
Acute Sinusitis 2.0%
Bronchiolitis 2.0%
Conjunctivitis 2.0%
Dyspnoea 2.0%
Febrile Infection 2.0%
Lung Disorder 2.0%
Otitis Media Acute 2.0%
Pain 2.0%
Respiratory Tract Infection 2.0%
International Normalised Ratio Increased 11.1%
Clostridium Difficile Colitis 7.4%
Pancreatitis Acute 7.4%
Pyrexia 7.4%
Systemic Lupus Erythematosus 7.4%
Tremor 7.4%
Drug Rash With Eosinophilia And Systemic Symptoms 3.7%
Drug Reaction With Eosinophilia And Systemic Symptoms 3.7%
Ear Haemorrhage 3.7%
Gamma-glutamyltransferase Increased 3.7%
Grand Mal Convulsion 3.7%
Liver Injury 3.7%
Melaena 3.7%
Mucous Stools 3.7%
Nephrotic Syndrome 3.7%
Overdose 3.7%
Purpura 3.7%
Rash Erythematous 3.7%
Rash Pustular 3.7%
Renal Tubular Necrosis 3.7%
Secondary
Drug Use For Unknown Indication 29.4%
Pyrexia 7.4%
Bronchitis 6.9%
Sinusitis 6.4%
Product Used For Unknown Indication 5.9%
Multiple Myeloma 5.4%
Lymphoma 4.9%
Renal Colic 4.9%
Lobar Pneumonia 3.9%
Nasopharyngitis 3.4%
Tonsillitis 3.4%
Diffuse Large B-cell Lymphoma 2.5%
Hypertension 2.5%
Acute Sinusitis 2.0%
Bone Pain 2.0%
Febrile Bone Marrow Aplasia 2.0%
Ovulation Induction 2.0%
T-cell Type Acute Leukaemia 2.0%
Tooth Disorder 2.0%
Gastritis 1.5%
Intra-uterine Death 14.3%
Stillbirth 12.2%
Orthostatic Hypotension 8.2%
Thrombotic Thrombocytopenic Purpura 8.2%
Clostridium Difficile Colitis 6.1%
Hepatitis 6.1%
Mania 4.1%
Pseudomembranous Colitis 4.1%
Pyrexia 4.1%
Rash Pustular 4.1%
Systemic Lupus Erythematosus 4.1%
Toxic Skin Eruption 4.1%
Urticaria 4.1%
Weight Decreased 4.1%
Agranulocytosis 2.0%
Anosmia 2.0%
Colitis Ischaemic 2.0%
Diarrhoea 2.0%
Drug Exposure During Pregnancy 2.0%
Drug Interaction 2.0%
Concomitant
Drug Use For Unknown Indication 26.0%
Pneumonia 10.7%
Ear Infection 5.3%
Premedication 4.7%
Prophylaxis 4.7%
Pyrexia 4.7%
Sinusitis 4.1%
Urinary Tract Infection 4.1%
Asthma 3.6%
Epilepsy 3.6%
Her-2 Positive Breast Cancer 3.6%
Influenza 3.6%
Osteoporosis 3.6%
Bronchitis 3.0%
Product Used For Unknown Indication 3.0%
Acth Decreased 2.4%
Acute Sinusitis 2.4%
Antibiotic Prophylaxis 2.4%
Neuralgia 2.4%
Neuritis 2.4%
Tendonitis 15.2%
Clostridium Difficile Colitis 6.1%
Lung Disorder 6.1%
Rash 6.1%
Sputum Purulent 6.1%
Stevens-johnson Syndrome 6.1%
Toxic Skin Eruption 6.1%
Tremor 6.1%
Urticaria 6.1%
Visual Field Defect 6.1%
Cardiac Arrest 3.0%
Coma 3.0%
Drug Exposure During Pregnancy 3.0%
Gamma-glutamyltransferase Increased 3.0%
Gingival Bleeding 3.0%
Haematemesis 3.0%
Hemiplegia 3.0%
Hepatic Enzyme Increased 3.0%
Hypoglycaemic Coma 3.0%
Hypothermia 3.0%
Interacting
Hypertension 21.2%
Helicobacter Infection 18.2%
Pneumonia 12.1%
Product Used For Unknown Indication 7.6%
Aortic Valve Replacement 6.1%
Cardiac Failure Chronic 6.1%
Chronic Obstructive Pulmonary Disease 6.1%
Hyperlipidaemia 6.1%
Tachyarrhythmia 6.1%
Atrial Fibrillation 4.5%
Bronchitis 3.0%
Arrhythmia Supraventricular 1.5%
Hypercholesterolaemia 1.5%
Drug Interaction 57.1%
International Normalised Ratio Increased 28.6%
Weight Decreased 14.3%